Log inStart free trialBook a demo
Book a demoLog inStart free trial
Media Database
>
Katie Kalvaitis

Katie Kalvaitis

Editorial Director / Medical Editor & Reporter at Cardiology - Healio

Contact this person
Email address
k*****@*******.comGet email address
Influence score
41
Phone
(XXX) XXX-XXXX Get mobile number
Location
United States
Languages
  • English
Covering topics
  • Health & Medicine

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

healio.com

Cardiac arrest rates during long-distance running races ‘relatively stable’ in recent years

CHICAGO — Good news for long-distance runners: The incidence of sudden cardiac arrest during marathons and half-marathons remained relatively stable over the past 2 decades, while the risk for sudden cardiac death markedly declined.New data from the Race Associated Cardiac Event Registry (RACER) on more than 29 million participants of marathons and half-marathons in the U.S. were presented
22 days ago
healio.com

Dapagliflozin benefits older patients with heart failure undergoing...

CHICAGO — The first trial to evaluate use of an SGLT2 inhibitor in people undergoing transcatheter aortic valve replacement showed benefit with dapagliflozin compared with standard care alone, including in older patients. “Among elderly patients with aortic stenosis undergoing TAVI and at high risk for heart failure, dapagliflozin was safe and reduced the incidence of all-cause death
23 days ago
healio.com

Cannabis use tied to elevated heart attack risk in younger adults

Cannabis use tied to elevated heart attack risk in younger adults
25 days ago
healio.com

The year in hypertension: Novel treatment options, a new era for re...

In the past year, there have been a number of practice-changing trials and approvals for the management of hypertension.At the Cardiometabolic Health Congress (CMHC) in October, Keith C. Ferdinand, MD, the Gerald S. Berenson Endowed Chair in Preventive Cardiology, professor of medicine in the John W. Deming Department of Medicine at Tulane University School of Medicine and a member of the Healio
4 months ago
healio.com

‘Please talk about it’: Patients with heart disease want more guida...

CHICAGO — Results from a new survey highlight a gap between patients’ information needs about sexual health and the actual support provided by health care professionals.In a small survey of patients with CVD in Sweden, 78% expressed a need for information about sexual health, but only 5% reported receiving this information.
5 months ago
healio.com

Heart failure drug may be ‘cardioprotective strategy’ for high-risk...

CHICAGO — Treatment with the heart failure medication sacubitril/valsartan was associated with a lower risk for chemotherapy-related heart damage among high-risk patients with cancer, according to preliminary results of the SARAH trial.Researchers assessed the effects of the angiotensin receptor/neprilysin inhibitor sacubitril/valsartan (Entresto, Novartis) on prevention of cardiotoxicity
5 months ago
healio.com

Rivaroxaban fails to prevent cognitive decline, stroke in younger a...

CHICAGO — In the BRAIN-AF trial, daily rivaroxaban did not reduce the incidence of cognitive decline, stroke or transient ischemic attack, compared with placebo, among younger patients with atrial fibrillation and low stroke risk.BRAIN-AF is the first large trial to focus on assessing whether a blood thinner can reduce risk for cognitive decline, stroke or TIA among adults younger than 65
5 months ago
healio.com

New life for used devices: Refurbished pacemakers address global di...

CHICAGO — Reconditioned cardiac devices could help meet an overwhelming need outside of the United States.In a new study presented at the American Heart Association Scientific Sessions, pacemakers that were reconditioned with an FDA-approved protocol were safe and worked as well as new devices among patients with an indication for a pacemaker living in Venezuela, Nigeria, Paraguay, Kenya,
5 months ago
healio.com

Lower is better: BPROAD trial backs intensive blood pressure target...

CHICAGO — An intensive blood pressure strategy resulted in a lower incidence of major cardiovascular events compared with a more standard strategy among patients with type 2 diabetes and elevated systolic blood pressure in the BPROAD trial.The BPROAD trial aimed to determine the optimal systolic BP control target for patients with type 2 diabetes. To date, other trials that examined this
5 months ago
healio.com

Left atrial appendage closure safe, effective first-line option for...

CHICAGO — In the OPTION trial, left atrial appendage closure resulted in similar thromboembolic protection but superior bleeding outcomes compared with oral anticoagulation among patients who underwent ablation for atrial fibrillation. OPTION is the first head-to-head comparison of left atrial appendage (LAA) closure with the Watchman FLX device (Boston Scientific) and oral anticoagulation
5 months ago
healio.com

Breast arterial calcification on mammograms may be marker for futur...

CHICAGO — The presence of breast arterial calcifications on routine mammograms may signal increased risk for atherosclerotic CVD later in life, according to research presented at the Annual Meeting of The Menopause Society.“It may be surprising that a mammogram can provide information beyond breast cancer screening, including heart health. However, examining the vessels in the breast
7 months ago